Circulating Tumor Cell, Cell Free DNA and Exosome/Microvesicle Cancer Diagnostics

...

GRAIL Details Plans for Early Cancer Detection Trials, Products

Early Cancer Detection Startup GRAIL Closes on $900 Million in Series B Funding

LinkedIn Top Companies: The 50 Most Sought-after Startups

Early Cancer-Detection Startup GRAIL is Reportedly Trying to Raise More Money

PARP Inhibitor May Be Effective Against Some TNBC-Lacking BRCA Mutations

How Science is Unlocking the Cancer Medicines of the Future

Genomic Medicine Has Entered the Building

Healthcare is Looking to the Tech World for Recruitment